A, B and O(H) isoantigens in tumor of the urinary bladder. Preliminary results, relating the specific red cell adherence test to pathological grade and stage.
In a prospective study we have included the specific red cell adherence (SRCA) test for the identification of blood group isoantigens in the investigation of patients with bladder tumor. The preliminary results, relating the SRCA test to grade and stage in 50 patients are presented. None of the SRCA-positive tumors were of high-grade malignancy (WHO III), and only SRCA-negative tumors had invasive properties at the time of investigation. 8 of 9 patients with carcinoma in situ were SRCA-negative.
D000017:ABO Blood-Group System / Q000276:immunology*; D002448:Cell Adhesion; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D006801:Humans; D007519:Isoantigens / Q000032:analysis*; D008297:Male; D009367:Neoplasm Staging; D011379:Prognosis; D011446:Prospective Studies; D001749:Urinary Bladder Neoplasms / Q000097:blood* / Q000473:pathology
D000017:ABO Blood-Group System; D007519:Isoantigens